Epidemiological trends of HIV-1 infection in blood donors from Catalonia, Spain (2005-2014)

Transfusion

Volumn 57, Issue 9, 2017, Pages 2164-2173

  Bes, Marta ^a,b   Piron, Maria ^a,b   Casamitjana, Natàlia ^a   Gregori, Josep ^b,c,d   Esteban, Juan Ignacio ^b,c,e   Ribera, Esteban ^c,e   Quer, Josep ^b,c   Puig, Lluís ^a,b   Sauleda, Sílvia ^a,b  

^a BANC DE SANG I TEIXITS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d Roche Diagnostics SL   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ARTICLE; BLOOD DONOR; CATALONIA; CONTROLLED STUDY; DEMOGRAPHY; DNA SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE B; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; NEIGHBOR JOINING METHOD; PHYLOGENY; PREVALENCE; RISK FACTOR; ANTIVIRAL RESISTANCE; GENETICS; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; MIGRATION; MUTATION; SPAIN; SUPPLY AND DISTRIBUTION; TRANSMISSION; YOUNG ADULT;

ADULT; BLOOD DONORS; DRUG RESISTANCE, VIRAL; EMIGRATION AND IMMIGRATION; HIV INFECTIONS; HIV-1; HUMANS; MUTATION; PHYLOGENY; PREVALENCE; SEQUENCE ANALYSIS, DNA; SPAIN; YOUNG ADULT;

EID: 85021840016     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14195     Document Type: Article

References (36)

1. The Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS report on the global AIDS epidemic 2013 [cited 2017 Jan 01]. Geneva (Switzerland): UNAIDS; 2013. Available from: http://www.unaids.org/sites/default/files/media_asset/UNAIDS_Global_Report_2013_en_1.pdf.
2. Wain-Hobson S. HIV genome variability in vivo. AIDS 1989;3Suppl 1:S13-8.
3. Gao F, Bailes E, Robertson DL, et al. Origin of HIV-1 in the chimpanzee Pan troglodytes. Nature 1999;397:436-41.
4. Peeters M, Honoré C, Huet T, et al. Isolation and partial characterization of an HIV-related virus occurring naturally in chimpanzees in Gabon. AIDS 1989;3:625-30.
5. Plantier JC, Leoz M, Dickerson JE, et al. A new human immunodeficiency virus derived from gorillas. Nat Med 2009;15:871-2.
6. Robertson DL, Anderson JP, Bradac JA, et al. HIV-1 nomenclature proposal. Science 2000;288:55-6.
7. Hemelaar J, Gouws E, Ghys PD, et al. Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 2011;25:679-89.
8. Abecasis AB, Wensing AM, Paraskevis D, et al. HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics. Retrovirology 2013;10:7.
9. Paraskevis D, Kostaki E, Beloukas A, et al. Molecular characterization of HIV-1 infection in Northwest Spain (2009-2013): investigation of the subtype F outbreak. Infect Genet Evol 2015;30:96-101.
10. Yebra D, de Mulder M, Martin L, et al. Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naive HIV-infected patients (CoRIS) are due to recombinant viruses. J Clin Microbiol 2012;50:407-13.
11. Thomson MM, Fernández-García A, Delgado E, et al. Rapid expansion of a HIV-1 subtype F cluster of recent origin among men who have sex with men in Galicia, Spain. J Acquir Immune Defic Syndr 2012;59:e49-51.
12. Ambrosioni J, Sued O, Nicolas D, et al. Trends in transmission of drug resistance and prevalence of non-B subtypes in patients with acute or recent HIV-1 infection in Barcelona in the last 16 years (1997-2012). PLoS One 2015;10:e0125837.
13. TenoRes Study Group. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. Lancet Infect Dis 2016;16:565-75.
14. Vetter B, Orlowski V, Niederhauser C, Walter L, Schüpbach J. Impact of naturally occurring amino acid variations on the detection of HIV-1 p24 in diagnostic antigen tests. BMC Infect Dis 2015;15:468.
15. Drosten C, Seifried E, Roth WK. TaqMan 5′-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening. J Clin Microbiol 2001;39:4302-8.
16. Roth WK, Weber M, Buhr S, et al. Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe. Transfusion 2002;42:862-8.
17. Zhou Z, Wagar N, DeVos JR, et al. Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited setting. PLoS One 2011;6:e28184.
18. R Core Team. R: a language and environment for statistical computing [cited 2017 Jan 01]. Vienna (Austria): R Foundation for Statistical Computing; 2013. Available from: http://www.R-project.org/.
19. Paradis E, Claude J, Strimmer K. APE: analyses of phylogenetics and evolution in R language. Bioinformatics 2004;20:289-90.
20. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987;4:406-25.
21. Wensing AM, Calvez V, Günthard HF, et al. 2014 Update of drug resistance mutations in HIV-1. Top Antivir Med 2014;22:642-50.
22. European Center for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2013 [cited 2017 Jan 01]. Stockholm (Sweden): European Center for Disease Prevention and Control; 2013. Available from: http://ecdc.europa.eu/en/publications/Publications/hiv-aids-surveillance-report-Europe-2013.pdf
23. Suligoi B, Raimondo M, Regine V, Salfa MC, Camoni L. Epidemiology of human immunodeficiency virus infection in blood donors in Europe and Italy. Blood Transfus 2010;8:178-85.
24. Slot E, Janssen MP, Marijt-van der Kreek, et al. Two decades of risk factors and transfusion-transmissible infections in Dutch blood donors. Transfusion 2016;56:203-14.
25. Delwart E, Slikas E, Stramer SL, et al. Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors. J Infect Dis 2012;205:875-85.
26. Paraschiv S, Otelea D, Batan I, et al. Molecular typing of the recently expanding subtype B HIV-1 epidemic in Romania: evidence for local spread among MSM in Bucharest area. Infect Genet Evol 2012;12:1052-7.
27. Tamalet C, Ravaux I, Moreau J, et al. Emergence of clusters of CRF02_AG and B human immunodeficiency viral strains among men having sex with men exhibiting HIV primary infection in southeastern France. J Med Virol 2015;87:1327-33.
28. Treviño A, Soriano V, Rodríguez C, et al. Changing rate of non-B subtypes and coinfection with hepatitis B/C virus in newly diagnosed HIV type 1 individuals in Spain. AIDS Res Hum Retroviruses 2011;27:633-8.
29. McConnell MJ, Docobo-Pérez F, Mata RC, et al. Molecular epidemiology of HIV type 1 in newly diagnosed patients in southern Spain. AIDS Res Hum Retroviruses 2008;24:881-7.
30. Fernández-García A, Pérez-Álvarez L, Cuevas M, et al. Identification of new HIV type 1 circulating BF intersubtype recombinant form (CRF47_BF) in Spain. AIDS Res Hum Retroviruses 2010;26:827-32.
31. Cuevas MT, Fernández-García A, Pinilla M, et al. Short communication: biological and genetic characterization of HIV type 1 subtype B and nonsubtype B transmitted viruses: usefulness for vaccine candidate assessment. AIDS Res Hum Retroviruses 2010;26:1019-25.
32. Vega Y, Delgado E, Fernández-García A, et al. Epidemiological surveillance of HIV-1 transmitted drug resistance in Spain in 2004-2012: relevance of transmission clusters in the propagation of the resistance. PLoS One 2015;10:e0125699.
33. Yebra G, Delgado R, Pulido F, et al. Different trends of transmitted HIV-1 drug resistance in Madrid, Spain, among risk groups in the last decade. Arch Virol 2014;159:1079-87.
34. Pineda-Peña AC, Schrooten Y, Vinken L, et al. Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic. PLoS One 2014;7:e101738.
35. Descamps D, Assoumou L, Chaix ML, et al. National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011. J Antimicrob Chemother 2013;68:2626-31.
36. Rhee SY, Blanco JL, Jordan MR, et al. Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and-sequence-level meta-analysis. PLoS Med 2015;12:e1001810.